Guided Therapeutics (GTHP) Other Non-Current Liabilities (2013 - 2026)
Guided Therapeutics' (GTHP) quarterly Other Non-Current Liabilities came in at $37000.0 in Q1 2026, down 43.94% year-over-year from $66000.0 in Q1 2025, and little changed quarter-over-quarter from $37000.0 in Q4 2025.
Powered by 
Analysis
Guided Therapeutics (GTHP) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Other Non-Current Liabilities across 13 years of filings, most recently posting $37000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 43.94% year-over-year to $37000.0; the TTM figure through Mar 2026 stood at $37000.0 (down 43.94% YoY), while the FY2025 annual figure was $37000.0, down 68.64% from the prior year.
- Other Non-Current Liabilities came in at $37000.0 for Q1 2026 at Guided Therapeutics, roughly flat from $37000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $118000.0 in Q4 2024 to a low of -$24000.0 in Q2 2022.
- Average Other Non-Current Liabilities over 4 years is $36909.1, with a median of $37000.0 recorded in 2025.
- Year-over-year, Other Non-Current Liabilities slumped 182.76% in 2022 and soared 361.54% in 2025.
- Over 4 years, Other Non-Current Liabilities stood at $5000.0 in 2022, then surged by 2260.0% to $118000.0 in 2024, then plunged by 68.64% to $37000.0 in 2025, then changed by 0.0% to $37000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $37000.0 in Q1 2026, $37000.0 in Q4 2025, and $79000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.41 Bn | 175.81 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.42 Bn | 122.20 Bn | 1.96 Bn |
| 3 | Medtronic | 117.31 Bn | 108.49 Bn | 6.34 Bn |
| 4 | Stryker | 105.19 Bn | 101.72 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.84 Bn | 64.30 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn |
| 7 | Alcon | 33.12 Bn | 31.66 Bn | 1.68 Bn |
| 8 | Dexcom | 32.09 Bn | 30.15 Bn | 830.00 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 19.31 Mn | 19.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | -38,000.00 |
| Jun 30, 2021 | 29,000.00 |
| Mar 31, 2021 | 113,000.00 |
| Dec 31, 2020 | -32,000.00 |
| Sep 30, 2020 | 5.52 Mn |
| Jun 30, 2020 | 7.58 Mn |
| Mar 31, 2020 | 1.80 Mn |
| Dec 31, 2019 | 5.09 Mn |